
FDA Authorizes Pfizer Covid-19 Booster Shots For Children Ages 5 To 11
The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.